Skip to main content

Correction to: Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity

  • The original article was published in Journal of Cardiothoracic Surgery 2019 14:7

Correction to: J Cardiothorac Surg (2019) 14:7

https://doi.org/10.1186/s13019-018-0829-z

The original article [1] contained an error whereby all authors’ names were mistakenly inverted. This error has now been corrected.

Reference

  1. 1.

    Aravot D, et al. Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity. J Cardiothorac Surg. 2019;14:7 https://doi.org/10.1186/s13019-018-0829-z.

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Yaron D. Barac.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Aravot, D., Barac, Y.D., Krutzwald-Josefson, E. et al. Correction to: Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity. J Cardiothorac Surg 14, 37 (2019). https://doi.org/10.1186/s13019-019-0856-4

Download citation